Literature DB >> 22262197

The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.

Emmannouil Pyleris1, Evangelos J Giamarellos-Bourboulis, Dimitrios Tzivras, Vassilios Koussoulas, Charalambos Barbatzas, Mark Pimentel.   

Abstract

OBJECTIVES: Many studies have linked irritable bowel syndrome (IBS) with small intestinal bacterial overgrowth (SIBO), although they have done so on a qualitative basis using breath tests even though quantitative cultures are the hallmark of diagnosis. The purpose of this study was to underscore the frequency of SIBO in a large number of Greeks necessitating upper gastrointestinal (GI) tract endoscopy by using quantitative microbiological assessment of the duodenal aspirate.
METHODS: Consecutive subjects presenting for upper GI endoscopy were eligible to participate. Quantitative culture of aspirates sampled from the third part of the duodenum during upper GI tract endoscopy was conducted under aerobic conditions. IBS was defined by Rome II criteria.
RESULTS: Among 320 subjects enrolled, SIBO was diagnosed in 62 (19.4%); 42 of 62 had IBS (67.7%). SIBO was found in 37.5% of IBS sufferers. SIBO was found in 60% of IBS patients with predominant diarrhea compared with 27.3% without diarrhea (P = 0.004). Escherichia coli, Enterococcus spp and Klebsiella pneumoniae were the most common isolates within patients with SIBO. A step-wise logistic regression analysis revealed that IBS, history of type 2 diabetes mellitus and intake of proton pump inhibitors were independently and positively linked with SIBO; gastritis was protective against SIBO.
CONCLUSIONS: Using culture of the small bowel, SIBO by aerobe bacteria is independently linked with IBS. These results reinforce results of clinical trials evidencing a therapeutic role of non-absorbable antibiotics for the management of IBS symptoms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262197     DOI: 10.1007/s10620-012-2033-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.

Authors:  E C Lauritano; M Gabrielli; A Lupascu; A Santoliquido; G Nucera; E Scarpellini; F Vincenti; G Cammarota; R Flore; P Pola; G Gasbarrini; A Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2005-07-01       Impact factor: 8.171

Review 2.  Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth.

Authors:  Hyo-Rang Lee; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2006-08

3.  Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth.

Authors:  G Nucera; M Gabrielli; A Lupascu; E C Lauritano; A Santoliquido; F Cremonini; G Cammarota; P Tondi; P Pola; G Gasbarrini; A Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2005-06-01       Impact factor: 8.171

Review 4.  Irritable bowel syndrome and small intestinal bacterial overgrowth.

Authors:  David Yamini; Mark Pimentel
Journal:  J Clin Gastroenterol       Date:  2010 Nov-Dec       Impact factor: 3.062

5.  Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.

Authors:  Derek Yu; Frank Cheeseman; Stephen Vanner
Journal:  Gut       Date:  2010-11-26       Impact factor: 23.059

Review 6.  Abnormal breath testing in IBS: a meta-analysis.

Authors:  Eric D Shah; Robert J Basseri; Kelly Chong; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

Review 7.  Diagnosis of irritable bowel syndrome.

Authors:  Kevin W Olden
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 8.  Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.

Authors:  Eamonn M M Quigley
Journal:  J Dig Dis       Date:  2007-02       Impact factor: 2.325

9.  Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?

Authors:  Savio C Reddymasu; Sandra Sostarich; Richard W McCallum
Journal:  BMC Gastroenterol       Date:  2010-02-22       Impact factor: 3.067

10.  Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden.

Authors:  Lennart Welin; Annika Adlerberth; Kenneth Caidahl; Henry Eriksson; Per-Olof Hansson; Saga Johansson; Annika Rosengren; Kurt Svärdsudd; Catharina Welin; Lars Wilhelmsen
Journal:  BMC Public Health       Date:  2008-12-08       Impact factor: 3.295

View more
  52 in total

Review 1.  The impact of proton pump inhibitors on the human gastrointestinal microbiome.

Authors:  Daniel E Freedberg; Benjamin Lebwohl; Julian A Abrams
Journal:  Clin Lab Med       Date:  2014-09-24       Impact factor: 1.935

2.  Aciduric Strains of Lactobacillus reuteri and Lactobacillus rhamnosus, Isolated from Human Feces, Have Strong Adhesion and Aggregation Properties.

Authors:  Kyle B Klopper; Shelly M Deane; Leon M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2018-03       Impact factor: 4.609

Review 3.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

4.  Second-Generation Biomarker Testing for Irritable Bowel Syndrome Using Plasma Anti-CdtB and Anti-Vinculin Levels.

Authors:  Walter Morales; Ali Rezaie; Gillian Barlow; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2019-05-31       Impact factor: 3.199

Review 5.  The use of non-narcotic pain medication in pediatric gastroenterology.

Authors:  Adrian Miranda; Miguel Saps
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

6.  Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome.

Authors:  Haiyan Xu; Chen Ma; Feiyan Zhao; Ping Chen; Yahua Liu; Zhihong Sun; Lihong Cui; Lai-Yu Kwok; Heping Zhang
Journal:  Eur J Nutr       Date:  2020-11-22       Impact factor: 5.614

Review 7.  Gastroduodenal "Dysbiosis": a New Clinical Entity.

Authors:  Ayesha Shah; Mark Morrison; Gerald J Holtmann
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

8.  Obesity and Risk of Small Intestine Bacterial Overgrowth: A Systematic Review and Meta-Analysis.

Authors:  Karn Wijarnpreecha; Monia E Werlang; Kanramon Watthanasuntorn; Panadeekarn Panjawatanan; Wisit Cheungpasitporn; Victoria Gomez; Frank J Lukens; Patompong Ungprasert
Journal:  Dig Dis Sci       Date:  2019-10-11       Impact factor: 3.199

Review 9.  Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.

Authors:  Uday C Ghoshal; Kok-Ann Gwee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

10.  The effect of rifaximin on gut flora and Staphylococcus resistance.

Authors:  Mi-Sung Kim; Walter Morales; Andres Ardila Hani; Sharon Kim; Gene Kim; Stacy Weitsman; Christopher Chang; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2013-04-16       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.